Critical Consumer

Pharma Patient Connection: Insight is the Missing Link to Authenticity

This is based on a presentation I gave to DTC Perspectives’ Marketing to the Digital Consumer conference, October 12-13, 2011 in Fairfield New Jersey. Authenticity in Pharma-Patient Connection

Read the full article →

Pharma Companies that Can’t Handle Comments Should Get Off Facebook, Good Riddance!

Jonathan at Dose of Digital talks about pharma’s fear of Facebook pages centering around 2 issues that pharma thinks require 24/7 monitoring: Adverse Events and negative publicity. I hear the same excuse on why pharma companies are so scared to look at patient comments on blogs: adverse events. I’m sorry, but adverse events are happening [...]

Read the full article →

Pharma and Social Media: It’s Not About Controlling the Conversation, but Finding the Right Venues for Engagement

Now that Facebook Pages is to Marketing what LinkedIn Profiles is to Job Seeking – pharma companies are in pickle: Facebook is going to open up comments no matter what. This means pharma companies can no longer restrict people from commenting on their Facebook pages. Er…. DUH! Why is this big news? People get on [...]

Read the full article →

Why I Chose NOT to be a Doctor

I was once a premed. I chose not to become a doctor because I wasn’t truly interested in the profession, it was something I felt I “had” to do or “should” do because I happened to major in biology. And being a first generation Asian-American there was also pressure from being a “Tiger Cub”: we [...]

Read the full article →

FDA Has to Slow Down to Keep Up with Drug Companies

Steve Woodruff is hopping mad with the apparent gross inefficiency and indecision of the “guidance process” for pharma company promotional practices when it comes to social media, and I can’t blame him! But I’m on the FDA’s side this time. Let me say up front that I never liked how the FDA remains vague and [...]

Read the full article →

← Previous Entries